Xiaoyu Yuan

Program: Developmental Regenerative and Stem Cell Biology

Current advisor: Sheila A. Stewart, PhD

Undergraduate university: University of Wisconsin-Madison, 2022

Enrollment year: 2022

Research summary
Using cell and mouse models to investigate how adipose tissue remodeling promotes breast cancer recurrences.

Despite significant responses to initial treatments, upwards of 30% of breast cancer patients will experience a recurrence of their disease. Unfortunately, there are few clinical features that predict which patients will recur, relegating patients and their doctors to a wait-and-see approach where they must remain vigilant. Recent studies have reported that obese patients experience 35%-40% higher rates of recurrence than lean patients. Given the rising prevalence of obesity, the need for mechanistic studies to elucidate its contribution to breast cancer dormancy and recurrence is urgent.
Using a well-established syngeneic mouse model of ER+ breast cancer dormancy (D2.0R) breast cancer dormancy models, we demonstrate that dormant tumor cells persist within multiple tissues, including visceral adipose, a finding mirrored by CT imaging of metastatic breast cancer patients. We found that D2.0R cells remained dormant in the visceral fat of wildtype mice but were reactivated upon obesity, which is unexpectedly further accelerated by chemotherapy. To understand what microenvironment changes were induced and how they led to dormant tumor cell reactivation, we profiled the visceral fat using single-cell RNA sequencing and utilized a transgenic mouse model, depleting and neutralizng antibodies, and a well-established 3D in vitro system to elucidate cellular and molecular mechanisms.
HFD-induced adipocyte death recruited Trem2+ macrophages expressing cathepsin L, which activated the integrin-SRC-FAK pathway in dormant tumor cells, driving dormancy escape. Crucially, while the adipocyte death that is increased in obesity drove reactivation in adipose tissue, a GLP-1 agonist that reduced adipose size without cell death or macrophage recruitment prevented metastatic recurrence.
These findings identify adipose remodeling and Trem2+ macrophages as critical drivers of breast cancer recurrence and uncover an unanticipated therapeutic opportunity for GLP-1 agonists in protecting obese patients from metastatic reactivation.

Graduate publications